XENPROT Trademark

Trademark Overview


On Friday, December 27, 2024, a trademark application was filed for XENPROT with the United States Patent and Trademark Office. The USPTO has given the XENPROT trademark a serial number of 98925213. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, April 1, 2025. This trademark is owned by Jingtai Zhiyao Technology (Shanghai) Co., Ltd.. The XENPROT trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biochemical research and analysis; Conducting early evaluations in the field of new pharmaceuticals; Design of computer-simulated models; DNA screening for scientific research purposes; Pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for scientific research, namely, software for analyzing scientific and medical data that is necessary for pharmaceutical drug development and antibody development; Research and development of new products for others; Research and development services in the field of antibodies; Research in the field of artificial intelligence; Software as a service (SAAS) services featuring software for scientific research, namely, software for analyzing scientific and medical data that is necessary for pharmaceutical drug development and antibody development
xenprot

General Information


Serial Number98925213
Word MarkXENPROT
Filing DateFriday, December 27, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, April 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of stylized letters "XENPROT".
Pseudo MarkXEN PRO T
Pseudo MarkXEN PROT
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBiochemical research and analysis; Conducting early evaluations in the field of new pharmaceuticals; Design of computer-simulated models; DNA screening for scientific research purposes; Pharmaceutical research and development; Platform as a service (PAAS) featuring computer software platforms for scientific research, namely, software for analyzing scientific and medical data that is necessary for pharmaceutical drug development and antibody development; Research and development of new products for others; Research and development services in the field of antibodies; Research in the field of artificial intelligence; Software as a service (SAAS) services featuring software for scientific research, namely, software for analyzing scientific and medical data that is necessary for pharmaceutical drug development and antibody development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 27, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameJingtai Zhiyao Technology (Shanghai) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShanghai 201000
CN

Trademark Events


Event DateEvent Description
Friday, December 27, 2024NEW APPLICATION ENTERED
Wednesday, January 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 30, 2025NON-FINAL ACTION WRITTEN
Thursday, January 30, 2025ASSIGNED TO EXAMINER
Thursday, January 30, 2025NON-FINAL ACTION E-MAILED
Wednesday, March 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 26, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 30, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 1, 2025LETTER OF SUSPENSION E-MAILED
Tuesday, April 1, 2025SUSPENSION LETTER WRITTEN
Tuesday, April 1, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED